Olafsson Ragnar P, Kvaran Karol, Ketilsdottir Kristin, Hallgrimsdottir Kolbrun, Sigurdsson Emil L, Sigurdsson Engilbert
Faculty of Psychology, University of Iceland.
Faculty of Medicine, University of Iceland, Development Centre for Primary Healthcare in Iceland.
Laeknabladid. 2023 Nov;109(11):495-503. doi: 10.17992/lbl.2023.11.766.
Interest in the use of psychedelics has increased following reports of their possible therapeutic potential. However, little is known about the knowledge of and attitudes towards the substances among health care professional who provide treatment for mental disorders in Iceland. An online survey was therefore conducted among members of the Icelandic associations of psychiatrists, general practitioners and psychologists.
Respondents were 256 in total, including 177 psychologists, 38 psychiatrists and 41 general practitioners that provided information on their background, type of work, knowledge of and attitude towards different types of psychedelic substances and their views on optimal service delivery if psychedelics were approved by licencing authorities and used for treatment.
Around half of psychiatrists reported having received questions about treatment with psychedelics in their clinical work, compared to only 14,6% of general practitioners and 17,5% of psychologists. The majority of respondents had little, or no knowledge of the substances targeted in the survey. A majority also expressed negative attitudes towards treatment with psilocybin mushrooms, but was positive towards ongoing scientific research and felt that such a treatment should be prescribed and provided by psychiatrists. Moreover, the majority view was that psilocybin treatment should be provided in specialised clinics or psychiatric units in a hospital setting. Scientific articles on the topic, discussions with colleagues and information in the media were identified as having had most influence on respondents´ attitudes towards psychedelics. Most respondents were interested in further education on psychedelics.
Respondents among these three professions felt that the time has not yet come to use psychedelics in the treatment of mental disorders in Iceland but thought more education on psychedelics, their potential efficacy and adverse health effects is important given the increased interest in psychedelics.
随着迷幻药潜在治疗作用的报道，人们对其使用的兴趣有所增加。然而，在冰岛为精神障碍患者提供治疗的医护人员中，对于这些物质的了解和态度却知之甚少。因此，我们对冰岛精神科医生、全科医生和心理学家协会的成员进行了一项在线调查。
共有256名受访者，包括177名心理学家、38名精神科医生和41名全科医生，他们提供了自身背景、工作类型、对不同类型迷幻物质的了解和态度，以及如果迷幻药获得许可并用于治疗，他们对最佳服务提供方式的看法。
约一半的精神科医生报告称在临床工作中收到过关于迷幻药治疗的问题，相比之下，只有14.6%的全科医生和17.5%的心理学家收到过此类问题。大多数受访者对调查中涉及的物质了解很少或一无所知。大多数人对裸盖菇素治疗也持负面态度，但对正在进行的科学研究持积极态度，并认为这种治疗应由精神科医生开出处方并提供。此外，大多数人的观点是裸盖菇素治疗应在医院环境中的专科诊所或精神科病房进行。关于该主题的科学文章、与同事的讨论以及媒体报道被认为对受访者对迷幻药的态度影响最大。大多数受访者对迷幻药的继续教育感兴趣。
这三个专业的受访者认为，在冰岛，使用迷幻药治疗精神障碍的时机尚未成熟，但鉴于人们对迷幻药的兴趣增加，他们认为对迷幻药及其潜在疗效和健康不良影响进行更多教育很重要。
